Solid transdermal therapeutic system comprising UV absorber
The invention relates to a novel solid transdermal therapeutic system which comprises UV absorber and is designed particularly for photosensitive active pharmaceutical substances. Said UV-stable transdermal therapeutic system (TTS) is composed of a rear layer (1), at least one active substance-conta...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
11.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to a novel solid transdermal therapeutic system which comprises UV absorber and is designed particularly for photosensitive active pharmaceutical substances. Said UV-stable transdermal therapeutic system (TTS) is composed of a rear layer (1), at least one active substance-containing matrix (2), and a peelable protective film (3). An adhesive layer (4) and a separating layer (5) are selectively inserted between the rear layer (1) and the active substance-containing matrix (2). UV absorbers from the group of hydroxyphenyltriazines can be embedded in the rear layer (1), theactive substance-containing matrix (2), or the adhesive layer (4). The inventive TTS is provided with great stability while having a low UV absorber concentration, thus preventing or reducing especially the risk of a potential skin irritation.
本发明涉及具有UV吸收剂的新型固态透皮治疗系统,其特别设计用于光敏活性药物成分。所述UV-稳定透皮治疗系统(TTS)由背衬层1、至少个含活性成分的基质层2、及可分离的保护膜3组成,任选地在背衬层1和含活性成分的基质层2之间引入粘合层4和隔离层5。选自羟苯基三嗪类的UV吸收剂可以包埋在背衬层1或含活性成分的基质层2或粘合层4中。根据本发明的TTS以低的UV吸收剂 |
---|---|
Bibliography: | Application Number: CN201810889234 |